Science 37 Holdings, Inc.

Science 37 Holdings, Inc. (Nasdaq: SNCE) is a decentralized clinical trial technology company that completed its business combination with LifeSci Acquisition Corp., a blank-check company sponsored by LifeSci Capital LLC, in late 2021. LifeSci Acquisition Corp. conducted its IPO in 2020, targeting the healthcare and life sciences sector. The May 2021 Form 8-K filing with the SEC marked a key procedural step in the de-SPAC transaction. Science 37 provides a platform enabling pharmaceutical and biotech companies to conduct remote and hybrid clinical trials, positioning it within the digital health and clinical research technology space. Visit SpacDesk and sign up for full filing data, deal timelines, and sponsor analytics on SNCE and hundreds of other SPAC transactions.